| Date | Form | Description | Docs | XBRL | Pages |
| 05/01/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/17/23 | 8-K | Current report filing |
|
|
5 |
| 03/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 03/10/23 | 8-K | Current report filing |
|
|
24 |
| 01/27/23 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...